Intra-tumoral necroptosis not only promoted tumor antigen loading through tumor antigen presenting cells based on RIPK1/ RIPK3 ectopic activation, but also enhanced DC-, and CD8 + T cell-mediated anti-tumor immunity function, which might provide a new idea for current T-cell-based immunotherapy49–51. This evidence concerns the gene RIPK1 and neoplasm.